All Clinical Trials in United Kingdom

A listing of 3097 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

United Kingdom

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

A Comparison of Two Brief Interventions for People with Chronic Low Back Pain

NCT06218459

Recruiting

The goal is to undertake a Decentralized Randomized Pilot Feasibility study to inform the methods for a definitive Randomized Controlled Trial (RCT) (including recruitment success, participant experience, intervention delivery, safety, outcome measurement and sample size estimation). The main question is if the methods used are feasible for an adequately powered future RCT. Participants will be randomly allocated to receive either: Intervention - OldPain2Go® treatment or Placebo Control - Jacobs... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/25/2024

Locations: Norton Physiotherapy Centre, Norton, Stockton-on-Tees

Conditions: Low Back Pain

Learn More ›

Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

NCT03366545

Recruiting

The registry is primarily designed to assess outcome, efficacy and residual safety aspects of CRT based on long-term data from an unselected, real-life clinical set-up. Moreover, the observation of the patient status should help to find possible predictors for HF events and to identify areas of improvement for CRT and for CRT device settings.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/22/2024

Locations: Canberra Heart Rhythm Foundation, Canberra, Not set +120 locations

Canberra Heart Rhythm Foundation, Canberra, Not set

The Canberra Hospital, Canberra, Not set

Lyell McEwin Hospital, Elizabeth Vale, Not set

Liverpool Hospital, Liverpool, Not set

Sydney Adventist Hospital, Sydney, Not set

Westmead Hospital, Westmead, Not set

Westmead Private Hosptial, Westmead, Not set

Kepler Universitätsklinikum, Linz, Not set

Universitätsklinikum St. Pölten, St. Polten, Not set

Medizinische Universität Wien, Vienna, Not set

Imelda Ziekenhuis, Bonheiden, Not set

UZ Brussel, Brussels, Not set

CHR de la Citadelle - Liège, Liège, Not set

Fakultní nemocnice Olomouc, Olomouc, Not set

Institute for Clinical and Experimental Medicine (IKEM), Praha, Not set

Nemocnice České Budějovice, České Budějovice, Not set

CHU de Brest, Brest, Not set

Le Centre Hospitalier Universitaire de CAEN, Caen, Not set

Centre Hospitalier Louis Pasteur, Chartres, Not set

CHU Dupuytren Limoges, Limoges, Not set

CH Saint Philibert, Lomme, Not set

Centre Hospitalier Lorient, Lorient, Not set

Hopital de la Croix Rousse, Lyon, Not set

Hôpital privé Clairval, Marseille, Not set

Hopital de la Timone (CHU La Timone), Marseille, Not set

Hôpital Privé / Institute Jaques Cartier, Massy, Not set

Clinique les Fontaines, Melun, Not set

CHU Montpellier, Montpellier, Not set

Clinique du Millenaire, Montpellier, Not set

Hôpital privé du Confluent, Nantes, Not set

Hopital Pitie-Salpetriere, Paris, Not set

Hôpital Haut Lévêque, Pessac Cedex, Not set

Centre Hospitalier de Périgeux, Périgueux, Not set

Centre Hospitalier Mémorial de Saint-Lô, Saint-Lô, Not set

Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, Not set

Hôpitaux Universitaires de Strasbourg, Strasbourg, Not set

Centre Hospitalier de Rangueil, Toulouse, Not set

Clinique Pasteur Toulouse, Toulouse, Not set

Chru de Tours, Tours, Not set

CH de Valence, Valence, Not set

Centre Hospitalier Bretagne Atlantique Prosper Chubert, Vannes, Not set

Städtisches Klinikum St.Georg, Leipzig, Sachsen

Zentralklinik Bad Berka GmbH, Bad Berka, Not set

HDZ Bad Oeynhausen, Bad Oeynhausen, Not set

Maria Heimsuchung - Carita-Klinik Pankow, Berlin, Not set

Städtisches Klinikum Brandenburg GmbH, Brandenburg, Not set

Krankenhaus Buchholz und Winsen AöR, Buchholz, Not set

Universitätsklinikum Erlangen, Erlangen, Not set

Universitätsklinikum Giessen und Marburg, Gießen, Not set

KMG Klinikum Güstrow, Güstrow, Not set

Klinikum der Universität Jena, Jena, Not set

Bonifatius Hospital Lingen gGmbH, Lingen, Not set

Universitätsklinikum Schleswig-Holstein (UKSH) - Campus Lübeck, Lübeck, Not set

Carl-von-Basedow-Klinikum Saalekreis GmbH, Merseburg, Not set

Johannes Wesling Klinikum Minden, Minden, Not set

Klinikum der LMU / Campus Großhadern, München, Not set

Universitätsklinikum Münster, Münster, Not set

Städtische Kliniken Neuss -Lukaskrankenhaus- GmbH, Neuss, Not set

Klinikum Oldenburg GmbH, Oldenburg, Not set

Schüchtermann Klinik, Herzzentrum Osnabrück-Bad Rothenfelde, Rothenfelde, Not set

Universitätsklinikum Würzburg, Würzburg, Not set

State Hospital of Cardiology, Balatonfüred, Not set

Gottsegen György Országos Kardiológiai Intézet, Budapest, Not set

Semmelweis Medical University, Budapest, Not set

The University of Pécs, Pécs, Not set

Assuta Medical Center, Ashdod, Not set

Ben-Gurion University of the Negev, Be'er Sheva, Not set

Wolfson Medical Center, H̱olon, Not set

Shaare Zedek Medical Center, Jerusalem, Not set

Meir Medical Center, Kfar Saba, Not set

Rabin Medical Center, Petach Tikva, Not set

Kaplan Medical Center, Reẖovot, Not set

Chaim Sheba Medical Center, Tel HaShomer, Not set

Shamir Medical Center, Zerifin, Not set

Ospedale San Raffaele, Mailand, Not set

Policlinico Casilino, Roma, Not set

Kokura Memorial Hospital, Fukuoka, Not set

Hiroshima Prefectural Hospital, Hiroshima, Not set

Tokai University Hospital, Kanagawa, Not set

Kitasato University Hospital, Sagamihara, Not set

Saitama Medical University International Medical Center, Saitama, Not set

IMS Tokyo Katsushika General Hospital, Tokio, Not set

Juntendo University Hospital, Tokio, Not set

Fujita Health University Hospital, Toyoake, Not set

Saiseikai Yokohamashi Tobu Hospital, Yokohama, Not set

Pauls Stradins Clinical University Hospital, Riga, Not set

Szpital Kliniczny Przemienienia Pańskiego, Poznań, Not set

The National Cardiology Institute of Stefan Cardinal Wyszynski - National Research Institute, Warsaw, Not set

Medical University of Lodz, Łódź, Not set

Hospital de Santa Cruz, Carnaxide, Not set

Hospital de Santa Maria, Lisboa, Not set

Hospital de Santo António, Porto, Not set

Hospital Espirito Santo de Evora, Évora, Not set

Changi General Hospital, Singapore, Not set

SÚSCCH, Banská Bystrica, Not set

NÚSCH Bratislava a.s., Bratislava, Not set

East-Slovak Cardiology Institute (VUSCH), Košice, Not set

Mediclinic Panorama Hospital, Cape Town, Not set

Mediclinic Pietermaritzburg, Pietermaritzburg, Not set

Mediclinic Midstream, Pretoria, Not set

Unitas Hospital, Pretoria, Not set

Gateway Private Hospital, Umhlanga, Not set

Life Westville, Westville, Not set

Hospital General Universitario de Alicante, Alicante, Not set

Centro Médico Teknon, Barcelona, Not set

Hospital Universitario de Bellvitge, Barcelona, Not set

Hospital Universitario de Burgos, Burgos, Not set

Hospital Universitario Donostia, Donostia, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Virgen de la Victoria, Málaga, Not set

Hospital General Universitario de Valencia, Valencia, Not set

Hospital Universitario La Fé, Valencia, Not set

Hospital Álvaro Cunqueiro, Vigo, Not set

Universitätsspital Zürich, Zürich, Not set

Kaohsiung Veterans General Hospital, Kaohsiung City, Not set

Far Eastern Memorial Hospital, New Taipei City, Not set

National Yang Ming University Hospital, Yilan City, Not set

St. Peter's Hospital, Chertsey, Not set

Russells Hall Hospital, Dudley, Not set

Kettering General Hospital, Kettering, Not set

Royal Cornwall Hospitals NHS Trust, Truro, Not set

Conditions: Heart Failure

Learn More ›

Prospective Study of White Blood Cells

NCT04838171

Recruiting

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Gender:

ALL

Ages:

All

Trial Updated:

11/22/2024

Locations: Quell Investigator Site 01, London, Not set

Conditions: Autoimmune Diseases, Inflammation, Rejection; Transplant, Liver

Learn More ›

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

NCT03151629

Recruiting

Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000 men with advanced cancer, including men with mHSPC and M0/M1 CRPC. The goal is to establish a population-based registry and recruit patients across academic and community practices from Australia, Barbados, Brazil, Canada, Ireland, Jamaica, Kenya, Nigeria, Norway, Spain, South Africa, Sweden, Switzerland, the United Kingdom (UK), and the United States (US). Target accrual number and number of participating sites are subject to change based on accrual, funding, and interest in participation by other international sites. This cohort study will facilitate a better understanding of the variation in care and treatment of advanced prostate cancer across countries and across academia and community based practices. Detailed data will be collected from patients at study enrollment and then during follow-up, for a minimum of five years. Patients will be followed prospectively for overall survival, clinically significant adverse events, comorbidities, changes in cancer treatments, and PROMs. PROMs questionnaires will be collected at enrollment and every three months thereafter. Physician Questionnaires will be collected from all participating sites at patient enrollment, time of first change in treatment and/or one year follow-up, at each subsequent change of treatment, and discontinuation of treatment. As such, this registry will help identify the treatment sequences or combinations that optimize overall survival and PROMs for men with mHSPC and M0/M1 CRPC. By collecting blood at enrollment, time of first change in treatment and/or one year follow-up (plasma, cell free DNA, buffy coat / RNA), this registry will further identify and validate molecular phenotypes of disease that predict response and resistance to specific therapeutics. Additionally, every effort will be made to collect blood specimen at each subsequent change in treatment due to progression of disease. When feasible, existing tumor tissue may be collected for correlation with described blood based studies. All samples will be used for future research. This cohort study will provide the research community with a unique biorepository to identify biomarkers of treatment response and resistance. Read Less

Gender:

MALE

Ages:

21 years and above

Trial Updated:

11/21/2024

Locations: University of Alabama-Birmingham, Birmingham, Alabama +120 locations

University of Alabama-Birmingham, Birmingham, Alabama

University of Alabama- Tuscaloosa, Tuscaloosa, Alabama

University of California - Los Angeles, Los Angeles, California

University of California San Diego, San Diego, California

Yale University, New Haven, Connecticut

University of Florida, Gainesville, Florida

Mayo Clinic Jacksonville, Jacksonville, Florida

Moffitt Cancer Center, Tampa, Florida

Morehouse School of Medicine, Atlanta, Georgia

Emory Winship Cancer Institute, Atlanta, Georgia

University of Illinois at Chicago, Chicago, Illinois

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois

University of Chicago, Chicago, Illinois

Kishwaukee Cancer Center, DeKalb, Illinois

Delnor Cancer Center, Geneva, Illinois

Warrenville Cancer Center, Warrenville, Illinois

Tulane University, New Orleans, Louisiana

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

Chesapeake Urology Associates, Towson, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts

University of Michigan, Ann Arbor, Michigan

Karmanos Cancer Institute, Detroit, Michigan

University of Mississippi Medical Center, Jackson, Mississippi

NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York

Roswell Park Comprehensive Cancer Center, Buffalo, New York

VA Western New York Healthcare System, Buffalo, New York

Columbia University Medical Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Weill Cornell Medical Center, New York, New York

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Durham VA Medical Center, Durham, North Carolina

Duke Cancer Network, Durham, North Carolina

Duke University, Durham, North Carolina

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Oregon Health & Science University Hospital, Portland, Oregon

Doylestown Health, Doylestown, Pennsylvania

Thomas Jefferson University, Philadelphia, Pennsylvania

Fox Chase Cancer Center - Temple Health, Philadelphia, Pennsylvania

Reading Health System, West Reading, Pennsylvania

Ralph H. Johnson VA Medical Center, Charleston, South Carolina

William Jennings Bryan Dorn VAMC, Columbia, South Carolina

Memphis VA Medical Center, Memphis, Tennessee

Baptist Clinical Research Institute, Memphis, Tennessee

Baylor College of Medicine, Houston, Texas

University of Virginia, Charlottesville, Virginia

University of Washington Medical Center, Seattle, Washington

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

Royal Brisbane & Women's Hospital, Herston, Brisbane

St. Vincent's Hospital Sydney, Darlinghurst, New South Wales

Macquarie University, Sydney, New South Wales

Westmead Hospital, Sydney, New South Wales

Redland Hospital, Cleveland, Queensland

Princess Alexandra Hospital, Woolloongabba, Queensland

Eastern Health (Box Hill Hospital), Box Hill, Victoria

Peter MacCallum Cancer Centre, Melbourne, Victoria

Epworth Healthcare, Mount Waverley, Victoria

Australian Prostate Centre, Melbourne N., Not set

Australian Urology Associates, Melbourne, Not set

The University of the West Indies - Cave Hill Campus, Bridgetown, Not set

Tacchini Hospital, Bento Gonçalves, Rio Grande Do Sul

Hospital Beneficência Portuguesa, Bela Vista, São Paulo

Instituto do Câncer e Transplante, Curitiba, Not set

Centro de Pesquisa em Oncologia, Porto Alegre, Not set

Centro Paulista de Oncologia, São Paulo, Not set

Instituto Câncer do Estado de São Paulo, São Paulo, Not set

Cross Cancer Institute (Alberta Health Services), Edmonton, Alberta

BC Cancer Agency, Vancouver, British Columbia

Juravinski Cancer Centre, Hamilton, Ontario

Ottawa Hospital Cancer Centre, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec

CHU de Québec-Université Laval, Québec, Quebec

Beacon Hospital, Dublin, Leinster

Tallaght University Hospital, Dublin, Not set

St. Vincent's University Hospital, Dublin, Not set

Sligo University Hospital, Sligo, Not set

The University of the West Indies - Mona Campus, Kingston, Not set

University of Nairobi, Nairobi, Not set

Federal Medical Centre Abeokuta, Abeokuta, Not set

University of Ilorin Teaching Hospital, Ilorin, Not set

Lagos State University Teaching Hospital, Lagos, Not set

University of Maiduguri Teaching Hospital, Maiduguri, Not set

Oslo University Hospital, Oslo, Not set

The Medical Oncology Centre of Rosebank, Johannesburg, Gauteng

Steve Biko Academic Hospital, Pretoria, Gauteng

Groote Schuur Hospital, Cape Town, Not set

Vall d'Hebron Institute of Oncology, Barcelona, Catalunya

Institut Catalá d'Oncologia Badalona, Badalona, Not set

Fundació Institut Mar d'Investigacions Mèdiques (Hospital del Mar)., Barcelona, Not set

Hospital Clínic de Barcelona, Barcelona, Not set

Hospital Provincial de Castellón, Castellón De La Plana, Not set

Hospital Universitario La Princesa, Madrid, Not set

Hospital Clinico San Carlos, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Virgen de la Victoria, Málaga, Not set

Hospital Universitario Central de Asturias, Oviedo, Not set

Instituto Valenciano de Oncología, Valencia, Not set

Hospital Universitario Miguel Servet (Zaragoza), Zaragoza, Not set

Skane University Hospital, Malmö, Skane

Umea University Hospital, Umeå, Not set

Orebro University Hospital, Örebro, Not set

Universitätsspital Basel, Basel, Not set

Ente Ospedaliero Cantonale, Bellinzona, Not set

Kantonsspital Graubünden, Chur, Not set

Kantonsspital St. Gallen, Saint Gallen, Not set

Onkozentrum Zürich, Zürich, Not set

Universitätsspital Zürich, Zürich, Not set

University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire

Lister Hospital, Stevenage, Hertfordshire

Mount Vernon Cancer Centre, Northwood, Middlesex

Velindre Cancer Centre, Cardiff, Not set

University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, Not set

Guys St Thomas NHS Foundation Trust, London, Not set

The Royal Marsden NHS Foundation Trust, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Not set

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, Not set

South Tyneside District Hospital, South Shields, Not set

Sunderland Royal Hospital, Sunderland, Not set

Clatterbridge Cancer Centre, Wirral, Not set

Conditions: Prostate Cancer

Learn More ›

Effects of Online Metacognitive Training Group on Distressing Beliefs

NCT06703827

Recruiting

Psychosis is characterized by distorted perceptions of reality, often involving persecutory delusions. Research links these symptoms to cognitive biases like "jumping to conclusions." Despite mixed reviews of Cognitive Behavioral Therapy (CBTp) for psychosis, a study will explore metacognitive training (MCT) delivered online. This training will be tested over 10 weeks with participants from a psychosis service in Kent, assessing its effect through interviews and questionnaires before and after t... Read More

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

11/21/2024

Locations: Kent and Medway NHS and Social Care Partnership Trust, Maidstone, Kent

Conditions: Psychosis

Learn More ›

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

NCT03783416

Recruiting

The study seeks to investigate safety and efficacy of ixazomib (NINLARO), a proteasome inhibitor, in multiple sclerosis (MS). Participants will receive either ixazomib capsules or placebo capsules for up to 24 months.

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

11/20/2024

Locations: Royal London Hospital, Barts Health NHS Foundation Trust, London, Greater London

Conditions: Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Learn More ›

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

NCT04180371

Recruiting

This clinical trial is evaluating a drug called BT5528 alone and in combination with nivolumab in participants with advanced solid tumors historically known for expression of EphA2. The main goals of this study are to: * Find the recommended dose(s) of BT5528 that can be given safely to participants alone and in combination with nivolumab * Learn more about the side effects of BT5528 * Learn about how effective BT5528 is for the treatment of ovarian cancer, urothelial/bladder cancer, lung cance... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/20/2024

Locations: California Cancer Associates for Research and Excellence, Inc., Encinitas, California +31 locations

California Cancer Associates for Research and Excellence, Inc., Encinitas, California

University of California, San Diego (UCSD) - Medical Center, La Jolla, California

University of California - Irvine Medical Center, Orange, California

Sarah Cannon Research Institute at HealthONE, Denver, Colorado

Florida Cancer Specialists, Sarasota, Florida

Dana Farber Cancer Institute, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York

Stephenson Cancer Center (Oklahoma University), Oklahoma City, Oklahoma

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania

Women and Infants Hospital, Providence, Rhode Island

Sarah Cannon and HCA Research Institute, Nashville, Tennessee

MD Anderson Cancer Center, Houston, Texas

Virginia Cancer Specialists, Fairfax, Virginia

Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin

Institut Jules Bordet, Brussels, Not set

Cliniques Universitaires Saint-Luc, Bruxelles, Not set

Antwerp University Hospital (UZA), Edegem, Not set

Universitair Ziekenhuis Gent (UZ), Gent, Not set

Gachon University Gil Medical Center, Incheon, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Not set

Hospital Universitario Vall d'Hebron, Barcelona, Not set

Hospital Fundación Jimenez Diaz, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Centro Integral Oncologico Clara Campal, Madrid, Not set

Cambridge University Hospitals NHS Foundation Trust, Cambridge, Not set

The Leeds Teaching Hospitals NHS Trust Of Trust Headquarters, St James's University Hospital, Leeds, Not set

Sarah Cannon Research Institute UK, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Sir Bobby Robson Cancer Trials Research Centre, The Northern Center for Cancer Care, Freeman Hospital, Newcastle Upon Tyne, Not set

Conditions: Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer, Non-small Cell Lung Cancer, Head and Neck Cancer, Triple Negative Breast Cancer, Gastric/Upper Gastrointestinal Cancer

Learn More ›

London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound

NCT05208567

Recruiting

Heart Valve Disease and Heart failure contribute to 25% of hospital emergency admissions while heart failure alone has become one of the most common causes for hospitalisation in people over the age of 65. The burden of disease is likely to be high in a multi-ethnic community but there is a paucity of data. Management of heart valve disease requires appropriate surveillance and timely surgery. Similarly heart failure management requires treatment with medications aimed at slowing prevention of s... Read More

Gender:

ALL

Ages:

65 years and above

Trial Updated:

11/20/2024

Locations: St Bartholomews Hospital, London, Not set

Conditions: Heart Valve Diseases, Left Ventricular Dysfunction

Learn More ›

Investigate and Predict Aortic & Thoracic Surgery Persistenet Postsurgical Pain

NCT05369130

Recruiting

This is an observational clinical study aiming to further the wider understanding of patients who develop persistent pain after Thoracoabdominal Aorta surgery, a surgical cohort who are disproportionately affected. This will be undertaken through a prospective biopsychosocial characterisation of the phenotype of patients undergoing this operation. Increasing numbers of patients are undergoing surgery on the chest for treatment of heart or lung cancer disease. Over the last twenty years, the med... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/20/2024

Locations: St Bartholomew's Hospital, London, Not set

Conditions: Persistent Postsurgical Pain

Learn More ›

Air Pollution and Pregnancy

NCT06340971

Recruiting

We are an inter-disciplinary team of UK scientists with expertise in obstetrics, women's and child health, epidemiology, climate science, inflammation, computational modelling, machine learning and artificial intelligence. Together we have a long history with existing strengths underlying preterm birth research that crosses multiple disciplines and an excellent track record of publications and awards leading research in preterm birth. We aim to develop and validate a deep learning model to pred... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/20/2024

Locations: Tina Chowdhury, London, Not set +1 locations

Conditions: Premature Birth

Learn More ›

MEMRI and Kidney Disease

NCT06698614

Recruiting

Acute kidney injury (AKI) is common and costly.1 Although patients who suffer an episode of AKI may recover, many will go on to develop cardiovascular disease and chronic kidney disease (CKD). Cardiovascular disease is an important complication of AKI.2 Similar to AKI, CKD and kidney transplantation and kidney donation associations with cardiovascular disease.1 The risk of cardiovascular disease complications is also increased in patients with inflammatory diseases that affect the kidneys, such... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/20/2024

Locations: NHS Lothian, Edinburgh, Not set

Conditions: Acute Kidney Injury, Kidney Transplant, Vasculitis, Chronic Kidney Disease(CKD)

Learn More ›

Mucopolysaccharidosis I (MPS I) Registry

NCT00144794

Recruiting

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities. The objectives of the Registry are: * To evaluate the lon... Read More

Gender:

ALL

Ages:

All

Trial Updated:

11/19/2024

Locations: Phoenix Children's Hospital- Site Number : 840003, Phoenix, Arizona +179 locations

Phoenix Children's Hospital- Site Number : 840003, Phoenix, Arizona

Arkansas Childrens Hospital- Site Number : 840109, Little Rock, Arkansas

Southern California Permanente Medical Group- Site Number : 840108, Los Angeles, California

USC Health Sciences Center Dept of Genetics- Site Number : 840082, Los Angeles, California

Children's Hospital Oakland- Site Number : 840029, Oakland, California

Children's Hospital of Orange County- Site Number : 840074, Orange, California

Stanford Unviersity MC Dept of Genetics- Site Number : 840022, Palo Alto, California

UC Davis MIND Institute- Site Number : 840010, Sacramento, California

Loma Linda University Children's Hospital- Site Number : 840117, San Bernardino, California

University of California at San Diego- Site Number : 840007, San Diego, California

University of California at San Francisco- Site Number : 840051, San Francisco, California

Children's Hospital IMD Clinic- Site Number : 840069, Aurora, Colorado

University of Colorado at Denver Genetics Site Number : 840068, Aurora, Colorado

Yale - Site Number : 840047, New Haven, Connecticut

Children's National Medical Center- Site Number : 840067, Washington, District of Columbia

University of Florida Dept of Genetics- Site Number : 840083, Gainesville, Florida

University of Florida Pediatrics Genetics- Site Number : 840121, Jacksonville, Florida

The Atwal Clinic- Site Number : 840112, Jacksonville, Florida

University Of Miami SOM- Site Number : 840006, Miami, Florida

Pediatric Endocrine Associates- Site Number : 840017, Tampa, Florida

Emory University School of Medicine- Human Genetics- Site Number : 840060, Decatur, Georgia

Ann and Robert Lurie Children's Hospital- Site Number : 840011, Chicago, Illinois

Rush University Medical Center Genetics- Site Number : 840079, Chicago, Illinois

Indianapolis University School of Medicine- Site Number : 840027, Indianapolis, Indiana

University of Iowa- Site Number : 840032, Iowa City, Iowa

University of Louisville- Genetics- Site Number : 840030, Louisville, Kentucky

Ochsner Medical Center - Site Number : 840120, New Orleans, Louisiana

John Hopkins- Site Number : 840044, Baltimore, Maryland

Massachusetts General Hospital-Genetics- Site Number : 840062, Boston, Massachusetts

Boston Children's Hospital- Site Number : 840093, Boston, Massachusetts

Baystate Health- Site Number : 840002, Springfield, Massachusetts

University of Michigan Pediatrics- Site Number : 840107, Ann Arbor, Michigan

Children's Hospital of Michigan- Site Number : 840066, Detroit, Michigan

Children's Health Care- Site Number : 840114, Minneapolis, Minnesota

University of Minnesota Medical Center Pediatrics- Site Number : 840076, Minneapolis, Minnesota

Washington University of St. Louis- Site Number : 840100, Saint Louis, Missouri

University of Nebraska Medical Center- Pediatrics- Site Number : 840084, Omaha, Nebraska

Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada

Joseph M. Sanzari Children's Hospital- Site Number : 840101, Hackensack, New Jersey

Atlantic Health System- Site Number : 840099, Morristown, New Jersey

St. Peter's University Hospital- Site Number : 840016, New Brunswick, New Jersey

St. Joseph's Children's Hospital- Site Number : 840057, Paterson, New Jersey

Northwell Health- Site Number : 840102, Manhasset, New York

New York University School Of Medicine- Site Number : 840040, New York, New York

Metropolitan Hospital Center- Site Number : 840110, New York, New York

University of Rochester Medical Center SOM- Site Number : 840105, Rochester, New York

State University of New York- Site Number : 840052, Syracuse, New York

Duke University Medical Center Genetics Dept- Site Number : 840037, Durham, North Carolina

Cincinnati Children's Hospital-Genetics- Site Number : 840041, Cincinnati, Ohio

UHCMC- Site Number : 840119, Cleveland, Ohio

Nationwide Children's Hospital- Site Number : 840091, Columbus, Ohio

LSD Data Registry Site LLC- Site Number : 840094, Dublin, Ohio

Oregon Health and Science University- Site Number : 840080, Portland, Oregon

Children's Hospital of Philadelphia HUP Medical Genetics- Site Number : 840089, Philadelphia, Pennsylvania

Children's Hospital of Philadelphia- Site Number : 840034, Philadelphia, Pennsylvania

University of Pittsburgh- Site Number : 840023, Pittsburgh, Pennsylvania

Rhode Island Hospital Genetics- Site Number : 840053, Providence, Rhode Island

Greenwood Genetcs- Site Number : 840055, Greenville, South Carolina

Baylor Research Center- Site Number : 840058, Dallas, Texas

University of Utah Health Hospital- Site Number : 840092, Salt Lake City, Utah

University of Virginia School of Medicine-Pediatrics- Site Number : 840078, Charlottesville, Virginia

Children's Hospital of the Kings Daughters- Site Number : 840072, Norfolk, Virginia

Seattle Children's Hospital- Site Number : 840028, Seattle, Washington

University Of Washington Medical Center- Site Number : 840059, Seattle, Washington

Multicare Health System ¿ Mary Bridge Childrens Hospital- Site Number : 840115, Tacoma, Washington

Children's Hospital of Wisconsin-Pediatrics- Site Number : 840054, Milwaukee, Wisconsin

Investigational Site Number : 153032, Ciudad Autónoma de Buenos Aires, Buenos Aires

Investigational Site Number : 153130, Buenos Aires, Not set

Investigational Site Number : 151069, Westmead, New South Wales

Investigational Site Number : 152096, Brisbane, Queensland

Investigational Site Number : 150944, Brussels, Not set

Investigational Site Number : 150517, Brussels, Not set

Investigational Site Number : 151668, Leuven, Not set

Investigational Site Number : 154008, Roeselare, Not set

Centro de Pesquisa Clínica Prédio 21, 2o andar Hospital de Clínicas de Porto Alegre- Site Number : 076001, Porto Alegre, Rio Grande Do Sul

Hospital e Maternidade Celso Pierro - PUC-Campinas- Site Number : 076007, Campinas, São Paulo

Instituto Fernandes Figueira - FIOCRUZ- Site Number : 076004, Rio de Janeiro, Not set

Instituto de Genética e Erros Inatos do Metabolismo - IGEIM- Site Number : 076002, São Paulo, Not set

Investigational Site Number : 124014, Calgary, Alberta

Investigational Site Number : 124002, Edmonton, Alberta

Investigational Site Number : 124011, Vancouver, British Columbia

Investigational Site Number : 124019, Winnipeg, Manitoba

Investigational Site Number : 124022, Moncton, New Brunswick

Investigational Site Number : 124021, London, Ontario

Investigational Site Number : 124006, Toronto, Ontario

Investigational Site Number : 124018, Montreal, Quebec

Investigational Site Number : 124001, Sherbrooke, Quebec

Investigational Site Number : 152003, Los Angeles, Not set

Investigational Site Number : 152001, Talcahuano, Not set

Investigational Site Number : 170001, Bogotá, Not set

Investigational Site Number : 1910001, Zagreb, Not set

Investigational Site Number : 150659, Praha 2, Not set

Investigational Site Number : 151229, København Ø, Not set

Investigational Site Number : 818002, Cairo, Not set

Investigational Site Number : 818001, Cairo, Not set

Investigational Site Number : 250004, Bordeaux, Not set

Investigational Site Number : 250001, BRON Cedex, Not set

Investigational Site Number : 250002, Marseille Cedex 05, Not set

Investigational Site Number : 250005, Paris Cedex 12, Not set

Investigational Site Number : 250003, Paris, Not set

Investigational Site Number : 250006, Vandœuvre-lès-nancy, Not set

Investigational Site Number : 151368, Hamburg, Not set

Investigational Site Number : 150031, Mainz, Not set

Investigational Site Number : 344001, Kowloon, Not set

Investigational Site Number : 3480005, Pécs, Not set

Investigational Site Number : 356003, Ahmedabad, Not set

Investigational Site Number : 356001, Kolkata, Not set

Investigational Site Number : 3560004, Secunderabad, Not set

Investigational Site Number : 356002, Vellore, Not set

Investigational Site Number : 360001, Jakarta, Not set

Investigational Site Number : 154161, Dublin, Not set

Investigational Site Number : 380002, Ancona, Not set

Investigational Site Number : 380004, Cusano Milanino, Not set

Investigational Site Number : 380009, Firenze, Not set

Investigational Site Number : 380003, Genova, Not set

Investigational Site Number : 380007, Milano, Not set

Investigational Site Number : 380005, Napoli, Not set

Investigational Site Number : 380008, Padova, Not set

Investigational Site Number : 380006, Roma, Not set

Investigational Site Number : 380001, Udine, Not set

Investigational Site Number : 392102, Nangoku-shi, Kochi

Investigational Site Number : 392101, Tokyo, Not set

Investigational Site Number : 151149, Seoul, Gyeonggi-do

Investigational Site Number : 154286, Changwon-si, Gyeongsangnam-do

Investigational Site Number : 153178, Yangsan-si, Gyeongsangnam-do

Investigational Site Number : 154148, Yangsan, Gyeongsangnam-do

Investigational Site Number : 153191, Daejeon, Not set

Investigational Site Number : 153225, Jeonnam, Not set

Investigational Site Number : 153180, Seoul, Not set

Investigational Site Number : 153196, Seoul, Not set

Investigational Site Number : 153192, Seoul, Not set

Investigational Site Number : 153212, Seoul, Not set

Investigational Site Number : 153222, Seoul, Not set

Investigational Site Number : 154225, Kuwait, Not set

Investigational Site Number : 4220004, Beirut, Not set

Investigational Site Number : 458001, Jalan Pahang, Not set

Investigational Site Number : 458002, Kuala Lumpur, Not set

Investigational Site Number : 151171, Amsterdam, Not set

Investigational Site Number : 152029, Rotterdam, Not set

Investigational Site Number : 154264, Lahore, Not set

Investigational Site Number : 154266, Lahore, Not set

Investigational Site Number : 608001, Manila, Not set

Investigational Site Number : 150575, Warszawa, Not set

Investigational Site Number : 6200002, Coimbra, Not set

Investigational Site Number : 154177, Cluj Napoca, Not set

Investigational Site Number : 643001, Moscow, Not set

Investigational Site Number : 643002, Moscow, Not set

Investigational Site Number : 682004, Makkah, Not set

Investigational Site Number : 682001, Qatif, Not set

Investigational Site Number : 702001, Singapore, Not set

Investigational Site Number : 703001, Bratislava, Not set

Investigational Site Number : 7520001, Stockholm, Not set

Investigational Site Number : 154093, Chiayi, Not set

Investigational Site Number : 152152, Hualien, Not set

Investigational Site Number : 152246, Kaohsiung City, Not set

Investigational Site Number : 152244, Kaohsiung, Not set

Investigational Site Number : 151534, New Taipei City, Not set

Investigational Site Number : 151500, Putz City, Chia-yi, Not set

Investigational Site Number : 151181, Taichung, Not set

Investigational Site Number : 151179, Taichung, Not set

Investigational Site Number : 153248, Tainan City, Not set

Investigational Site Number : 152153, Tainan City, Not set

Investigational Site Number : 151182, Taipei City, Not set

Investigational Site Number : 152321, Taipei, Not set

Investigational Site Number : 153158, Taoyuan City, Not set

Investigational Site Number : 764002, Bangkok, Not set

Investigational Site Number : 764003, Bangkok, Not set

Investigational Site Number : 764004, Bangkok, Not set

Investigational Site Number : 764001, Bangkok, Not set

Investigational Site Number : 764005, Khon Kaen, Not set

Investigational Site Number : 152287, Birmingham, Not set

Investigational Site Number : 154240, Birmingham, Not set

Investigational Site Number : 152156, Glasgow, Not set

Investigational Site Number : 151646, London, Not set

Investigational Site Number : 151123, London, Not set

Investigational Site Number : 150303, London, Not set

Investigational Site Number : 150455, Manchester, Not set

Investigational Site Number : 152361, Salford, Not set

Investigational Site Number : 154212, Hanoi, Not set

Investigational Site Number : 704002, Ho Chi Minh City, Not set

Conditions: Mucopolysaccharidosis I (MPS I)

Learn More ›